VIP Health Care Portfolio
Data updated: 2026-05-26
C000021062 — VIP Health Care Portfolio data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $1.00B AUM · 0.59% expense ratio · 8.4% 1-yr return. From SEC regulatory filings.
C000021062 Fund Overview
VIP Health Care Portfolio is a US mutual fund managed by Variable Insurance Products Fund IV, categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Variable Insurance Products Fund IV
- Category: United States Health Care Equity
- Assets under management: $1.00B
- 1-year return: 8.4%
- SEC CIK: 0000720318
- SEC series ID: S000007742
- Share class ID: C000021062
C000021062 Holdings
Top 10 holdings of VIP Health Care Portfolio by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Danaher Corp. | 6.80% |
| ELI LILLY and CO | 6.67% |
| JOHNSON and JOHNSON | 5.91% |
| Boston Scientific Corp. | 5.06% |
| Abbvie, Inc. | 3.62% |
| Gilead Sciences, Inc. | 2.58% |
| Ucb SA | 2.55% |
| MERCK and CO INC | 2.52% |
| Ascendis Pharma A/s | 2.50% |
| Edwards Lifesciences Corp. | 2.07% |
C000021062 Portfolio Allocation
Asset-class allocation of VIP Health Care Portfolio by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.0% |
| Cash & Equivalents | 3.0% |
| Fixed Income | 0.1% |
C000021062 Performance
Total returns for C000021062 (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -6.2% |
| 1 year | 8.4% |
| 3 years (annualised) | 5.3% |
| 5 years (annualised) | 2.5% |
C000021062 Risk Information
Risk metrics for C000021062, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 14.6%
C000021062 Costs and Fees
C000021062 costs about $59 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.59%
- Gross expense ratio: 0.59%
- Portfolio turnover: 65%
- Brokerage commissions: 3.23 bps of average net assets (SEC N-CEN)
C000021062 Cashflows
Over the 12 months to 2026-03, VIP Health Care Portfolio had net outflows of $3.76M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | −$7.55M |
| 2026-02 | $81.81M |
| 2026-01 | −$13.59M |
| 2025-12 | −$5.39M |
| 2025-11 | −$2.20M |
| 2025-10 | −$11.38M |
C000021062 Debt Constituents
Largest debt holdings of VIP Health Care Portfolio by percentage of net assets, from the latest SEC N-PORT filing.
| Debt holding | % of net assets |
|---|---|
| Kardium Inc/us | 0.07% |
| Wugen, Inc. | 0.04% |
| Galvanize Therapeutics | 0.02% |
C000021062 Prospectus and SEC Filings
Official VIP Health Care Portfolio filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.